Polycarbophil Calcium Tablets 500mg (Polyful® / ポリフル錠500mg)

JPY ¥1,300

Japanese Irritable Bowel Syndrome Treatment Agent (Polycarbophil Calcium 500mg). Oral tablets for management of bowel irregularities and gastrointestinal symptoms in irritable bowel syndrome. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Viatris Pharmaceuticals LLC, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,196
10 - 19 12% JPY ¥1,144
20 + 18% JPY ¥1,066
SKU: PLF-500-TAB Category:

Description

Product Overview / 商品概要

Polycarbophil Calcium Tablets 500mg (ポリフル錠500mg)
Generic: Polycarbophil Calcium / ポリカルボフィルカルシウム
Therapeutic Category: Irritable Bowel Syndrome Treatment Agent / 過敏性腸症候群治療剤
Manufactured by: Viatris Pharmaceuticals LLC / ヴィアトリス製薬合同会社

Composition & Specification / 組成・規格

Active Ingredient: Polycarbophil Calcium (as dried substance) 500mg per tablet / 1錠中 ポリカルボフィルカルシウム 乾燥物として 500mg
Additives: Microcrystalline cellulose, Carmellose, Hydroxypropylcellulose, Magnesium stearate, Hypromellose, Macrogol 6000, Titanium oxide, Polyvinyl acetal diethylaminoacetate, Carnauba wax / 結晶セルロース、カルメロース、ヒドロキシプロピルセルロース、ステアリン酸マグネシウム、ヒプロメロース、マクロゴール6000、酸化チタン、ポリビニルアセタールジエチルアミノアセテート、カルナウバロウ
Appearance: White film-coated tablet. Identification code: HC237. Major axis: 17.8mm, Minor axis: 7.6mm, Thickness: 5.9mm, Weight: 785mg
外観: 白色フィルムコーティング錠。識別コード: HC237。長径17.8mm、短径7.6mm、厚さ5.9mm、重量785mg

Indications / 効能効果

EN: Bowel irregularities (diarrhea, constipation) and gastrointestinal symptoms associated with irritable bowel syndrome
JA: 過敏性腸症候群における便通異常(下痢、便秘)及び消化器症状

Dosage and Administration / 用法用量

EN: Usual adult dose: 1.5 to 3.0g of polycarbophil calcium per day, divided into 3 doses, administered orally with water after meals. Daily dose: 3 to 6 tablets.
JA: 通常、成人にはポリカルボフィルカルシウムとして1日量1.5~3.0gを3回に分けて、食後に水とともに経口投与する。1日投与量: 錠 3~6錠

Contraindications / 禁忌

EN: Patients with acute abdominal diseases (appendicitis, intestinal hemorrhage, ulcerative colitis, etc.); patients at risk of gastrointestinal obstruction such as post-operative ileus; patients with hypercalcemia; patients with renal calculi; patients with renal failure (excluding mild cases and those on dialysis); patients with a history of hypersensitivity to any component of this product
JA: 急性腹部疾患(虫垂炎、腸出血、潰瘍性結腸炎等)の患者、術後イレウス等の胃腸閉塞を引き起こすおそれのある患者、高カルシウム血症の患者、腎結石のある患者、腎不全(軽度及び透析中を除く)のある患者、本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 21200AMZ00462
Sales Started: October 2000 / 2000年10月
Classification Code: 872399
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 1,000 tablets [10 tablets (PTP) x 100]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Polycarbophil Calcium Tablets 500mg (Polyful® / ポリフル錠500mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Polycarbophil Calcium Tablets 500mg (Polyful®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.